Eli Lilly, Incyte arthritis drug meets endpoint in late-stage trial By: MarketWatch December 09, 2014 at 08:24 AM EST Drug proves effective for patients who had previously had inadequate response to conventional therapies. Read More >> Related Stocks: Eli Lilly Incyte Corp